Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
TripAdvisor
TRIP
$1.63B
| $10.7M | 0.01% |
309,256
+127,500
| +70% | +$4.61M |
|
1152
CALL
Workday
WDAY
$42.1B
| $10.6M | 0.01% |
104,300
+17,000
| +19% | +$1.82M |
|
1153
Leggett & Platt
LEG
$1.4B
| $10.6M | 0.01% |
221,938
+84,968
| +62% | +$4.01M |
|
1154
NOV
NOV
$6.95B
| $10.6M | 0.01% |
293,453
+155,832
| +113% | +$5.27M |
|
1155
CALL
Sarepta Therapeutics
SRPT
$1.68B
| $10.6M | 0.01% |
189,600
-65,200
| -26% | -$3.45M |
|
1156
PUT
Truist Financial
TFC
$64.6B
| $10.5M | 0.01% |
211,800
+3,800
| +2% | +$183K |
|
1157
PUT
Hain Celestial
HAIN
$50.3M
| $10.5M | 0.01% |
248,200
+113,600
| +84% | +$4.5M |
|
|
GAP
1158
PUT
The Gap Inc
GAP
$7.4B
| $10.5M | 0.01% |
308,500
-153,500
| -33% | -$4.58M |
|
1159
Advance Auto Parts
AAP
$3.59B
| $10.5M | 0.01% |
105,203
+15,062
| +17% | +$1.39M |
|
1160
CALL
Southern Company
SO
$107B
| $10.5M | 0.01% |
217,900
-43,500
| -17% | -$2.22M |
|
1161
CALL
T-Mobile US
TMUS
$186B
| $10.5M | 0.01% |
164,900
-254,600
| -61% | -$15.5M |
|
|
RSX
1162
PUT
DELISTED
VanEck Russia ETF
RSX
| $10.5M | 0.01% |
493,500
-26,100
| -5% | -$572K |
|
|
TFCFA
1163
CALL
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $10.4M | 0.01% |
302,500
+85,800
| +40% | +$2.56M |
|
1164
PUT
Nutanix
NTNX
$16.5B
| $10.4M | 0.01% |
294,600
+18,600
| +7% | +$564K |
|
1165
PUT
Carnival Corporation Ltd
CCL
$40.6B
| $10.4M | 0.01% |
156,400
-52,700
| -25% | -$3.49M |
|
1166
CALL
Kinder Morgan
KMI
$69.3B
| $10.4M | 0.01% |
572,900
+302,200
| +112% | +$5.42M |
|
1167
Douglas Emmett
DEI
$1.98B
| $10.3M | 0.01% |
251,199
+122,861
| +96% | +$4.96M |
|
1168
CALL
Alnylam Pharmaceuticals
ALNY
$30.6B
| $10.3M | 0.01% |
81,000
-173,800
| -68% | -$21.8M |
|
1169
CALL
TJX Companies
TJX
$177B
| $10.3M | 0.01% |
268,400
-60,200
| -18% | -$2.18M |
|
1170
Revvity
RVTY
$12.8B
| $10.2M | 0.01% |
139,810
+76,146
| +120% | +$5.46M |
|
1171
Eastman Chemical
EMN
$8.39B
| $10.2M | 0.01% |
110,309
+57,875
| +110% | +$5.26M |
|
1172
PUT
Neurocrine Biosciences
NBIX
$16.4B
| $10.2M | 0.01% |
131,600
-19,700
| -13% | -$1.34M |
|
|
TSRO
1173
CALL
DELISTED
TESARO, Inc.
TSRO
| $10.2M | 0.01% |
123,000
+8,300
| +7% | +$814K |
|
|
AMTD
1174
DELISTED
TD Ameritrade Holding Corp
AMTD
| $10.2M | 0.01% |
199,340
-287,182
| -59% | -$14.4M |
|
1175
Blackstone
BX
$109B
| $10.1M | 0.01% |
316,810
+86,691
| +38% | +$2.82M |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.